Move Over, BA.2.86 - JN.1 is the Dominant COVID-19 Variant

The CDC continues to track JN.1, one of the variants that causes COVID-19. As of December 23, 2023, JN.1 is projected to account for approximately 39-50% of circulating variants in the U.S. While JN.1 is becoming more prevalent, it appears that existing vaccines, tests and treatments are effective against it. Protect yourself and others with COVID-19 Prevention Actions.                                  

COVID-19, RSV and influenza infections continue to be of concern this post-holiday season. Vaccination is a key prevention tool. Equally important is testing when symptomatic and receiving early treatment. CDC’s Take Three Actions to Protect Against Flu gives beneficial information on what to do to prevent flu. For healthcare providers, CDC has updated its Immunization Courses to include webcasts and self-study, many of which provide continuing education (CE) credit.

COVID-19 Hospitalizations, ED Visits Increase

The greatest number of COVID-19 cases continue to be seen in adults 75 years and older.

Long-term care facilities are seeing an increase in confirmed COVID-19 cases, reporting 13/1000 cases for the week ending December 3.

Vaccination remains a vital tool to protect public health. One dose of the updated 2023-2024 Moderna, Pfizer, or Novavax vaccine is required for individuals to be considered up to date.

You can make a difference. Help keep your community safe and healthy. Remember to WAVE - ask "What About Vaccines?" at Every Encounter.